Skip to content
DataLookout
Menu

NCT07102186

Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris

StatusCompleted
PhasePhase 4
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 2 words Show 5 more changesShow less
    • Trial completed
    • Final enrollment: 93 participants (planned 120)
    • Secondary endpoints: details revised at 3 of 3 entries
    • Study description revised
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Local tolerance to the drugs scale
Timeframe: 8 weeks

Secondary (3)

investigator's global assessment (IGA)
acne severity index
skin turgor assessment

Arms and interventions

adapalene gel 0.1% once daily at bedtimeActive comparator
adapalene gel 0.1% once daily at bedtime and hyaluronic acidExperimental

Drugs: use of adapalene gel 0.1% and hyaluronic acid at bedtime, use of adapalene gel 0.1% once daily at bedtime

Sites

1 site in 1 country

  • Badr university in CairoCairo, Cairo Governorate, Egypt